INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 425m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
MA
Corporate insider

Mancini Anthony

See RemarksCIK 0002124509

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 10
Max Insider Score33
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M$105K
3,121 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Revolution Medicines, Inc.See Remarks · Sep 14, 2026
16
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL
$117K
587 sh
Sep 24, 2026
Sep 28, 2026
traded Sep 24, 2026
+4d
SEC FORM 4

Evidence

0
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M—
3,121 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC FORM 4

Evidence

23
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$626K
3,121 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC FORM 4

Evidence

19
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$347K
1,764 sh
Sep 18, 2026Sep 22, 2026
traded Sep 18, 2026
+4dSEC FORM 4

Evidence

22
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$348K
1,747 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

16
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$5,266
27 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

23
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
300 sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence

9
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M$315K
9,363 sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence

33
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$1.22M
6,019 sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence

33
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$1.13M
5,530 sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence

30
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$496K
2,420 sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence

3
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Option exercise · 10b5-1 plan
M—
9,363 sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence

23
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$243K
1,179 sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence